| scholarly article | Q13442814 |
| P356 | DOI | 10.1084/JEM.156.1.20 |
| P8608 | Fatcat ID | release_fxf53aqp5rfaxhtgblb6qu4ojy |
| P932 | PMC publication ID | 2186717 |
| P698 | PubMed publication ID | 7045272 |
| P50 | author | Ruth Nussenzweig | Q2177773 |
| P2093 | author name string | V Nussenzweig | |
| W E Collins | |||
| P Tapchaisri | |||
| E H Nardin | |||
| K T Harinasuta | |||
| Y Chomcharn | |||
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 | ||
| Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines | Q34345829 | ||
| Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection | Q36343693 | ||
| Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei | Q36345653 | ||
| Characterization of sporozoite surface antigens by indirect immunofluorescence: detection of stage- and species-specific antimalarial antibodies | Q36674780 | ||
| Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A | Q39513417 | ||
| Plasmodium vivax: Correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-lnduced protective immunity in man | Q40750226 | ||
| Immunization of man against sporozite-induced falciparum malaria | Q44157817 | ||
| Specificity of protection of man immunized against sporozoite-induced falciparum malaria | Q44157838 | ||
| Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum | Q44164016 | ||
| Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity | Q47955304 | ||
| Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites | Q47955309 | ||
| The protective antigen of malarial sporozoites (Plasmodium berghei) is a differentiation antigen. | Q47987835 | ||
| Antibodies to the protective antigen of Plasmodium berghei sporozoites prevent entry into cultured cells. | Q47992617 | ||
| ENZYMATIC DIGESTION OF RABBIT GAMMA GLOBULIN AND ANTIBODY AND CHROMATOGRAPHY OF DIGESTION PRODUCTS | Q78329670 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium vivax | Q311376 |
| Plasmodium falciparum | Q311383 | ||
| malaria | Q12156 | ||
| P304 | page(s) | 20-30 | |
| P577 | publication date | 1982-07-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax | |
| P478 | volume | 156 |
| Q28730779 | A Hybrid Multistage Protein Vaccine Induces Protective Immunity against Murine Malaria |
| Q37525951 | A blood stage antigen of Plasmodium falciparum shares determinants with the sporozoite coat protein |
| Q44168334 | A chemiluminescent-western blot assay for quantitative detection of Plasmodium falciparum circumsporozoite protein |
| Q54216698 | A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum |
| Q52350559 | A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite. |
| Q41058932 | A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge |
| Q42971169 | A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax |
| Q34261339 | A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts |
| Q27974493 | A multidomain adhesion protein family expressed in Plasmodium falciparum is essential for transmission to the mosquito |
| Q34537728 | A multilateral effort to develop DNA vaccines against falciparum malaria |
| Q33590269 | A no film slot blot for the detection of developing P. falciparum oocysts in mosquitoes |
| Q47581449 | A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII. |
| Q34889790 | A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys |
| Q33515022 | A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites |
| Q34758285 | A slot blot immunoassay for quantitative detection of Plasmodium falciparum circumsporozoite protein in mosquito midgut oocyst |
| Q58707703 | A sporozoite-based vaccination platform against human malaria |
| Q30044955 | AMA1 and MAEBL are important for Plasmodium falciparum sporozoite infection of the liver |
| Q47879434 | Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes. |
| Q34700810 | Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice |
| Q48018507 | An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens. |
| Q33830488 | An unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses |
| Q33570584 | Anopheles stephensi salivary glands bear receptors for region I of the circumsporozoite protein of Plasmodium falciparum |
| Q92965786 | Antibodies against Plasmodium falciparum malaria at the molecular level |
| Q36348872 | Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum |
| Q40484421 | Antibodies to the Circumsporozoite Protein and Protective Immunity to Malaria Sporozoites |
| Q34530938 | Antibody and B cell responses to Plasmodium sporozoites |
| Q40170204 | Antigenic Characterization of Plasmodia |
| Q35946430 | Antigenic diversity and immune evasion by malaria parasites. |
| Q39447157 | Antigens of Plasmodium falciparum blood stages with clinical interest cloned and expressed in E. coli |
| Q47977119 | Antigens of the erythrocytic stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies |
| Q68231229 | Assay, purification and characterization of a recombinant malaria circumsporozoite fusion protein by high-performance liquid chromatography |
| Q26314437 | Circumsporozoite protein as a potential target for antimalarials |
| Q33957574 | Circumsporozoite protein genes of malaria parasites (Plasmodium spp.): evidence for positive selection on immunogenic regions |
| Q36993585 | Circumsporozoite protein of the human malaria parasite Plasmodium ovale identified with monoclonal antibodies |
| Q34249872 | Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes |
| Q41825623 | Class II-restricted protective immunity induced by malaria sporozoites |
| Q36599630 | Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi |
| Q48036108 | Cloning and expression of the thrombospondin related adhesive protein gene of Plasmodium berghei |
| Q59387720 | Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin |
| Q36592513 | DNA Cloning of Plasmodium falciparum Circumsporozoite Gene: Amino Acid Sequence of Repetitive Epitope |
| Q48015403 | Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites |
| Q37134841 | Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides |
| Q37036065 | Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy |
| Q40207828 | Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32). |
| Q43796395 | Disruption of disulfide linkages of the Plasmodium falciparum circumsporozoite protein: effects on cytotoxic and antibody responses in mice |
| Q27974558 | Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites |
| Q39413199 | Distribution of repetitive and non-repetitive circumsporozoite protein epitopes on Plasmodium falciparum sporozoites and immunochemical characterization of human malaria antisera |
| Q36367649 | Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans |
| Q43583421 | Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques |
| Q37075435 | Enhanced immunogenicity of Plasmodium falciparum peptide vaccines using a topical adjuvant containing a potent synthetic Toll-like receptor 7 agonist, imiquimod |
| Q37099445 | Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3. |
| Q95832528 | Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs |
| Q36353517 | Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine |
| Q35662378 | Flow Cytometry Based Detection and Isolation of Plasmodium falciparum Liver Stages In Vitro |
| Q38777070 | Force Spectroscopy of the Plasmodium falciparum Vaccine Candidate Circumsporozoite Protein Suggests a Mechanically Pliable Repeat Region |
| Q31152863 | Fusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilities |
| Q34957552 | Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice |
| Q90069061 | Generation of Transmission-Competent Human Malaria Parasites with Chromosomally-Integrated Fluorescent Reporters |
| Q36352284 | Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine |
| Q37911988 | Genetic diversity in Plasmodium falciparum |
| Q45357412 | Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein |
| Q44164877 | Identification of circumsporozoite proteins in individual malaria-infected mosquitoes by Western blot analysis |
| Q36363602 | Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes |
| Q37546314 | Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents |
| Q47831323 | Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation |
| Q37469633 | Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica Serovar Typhimurium flagellin |
| Q34234390 | Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis |
| Q33521372 | Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data |
| Q41850061 | In-vitro exoerythrocytic development of Plasmodium cynomolgi bastianellii: inhibitory activity of monoclonal antibodies against sporozoites of different P. cynomolgi strains and of P. knowlesi |
| Q47863376 | Inability of Malaria Vaccine to Induce Antibodies to a Protective Epitope Within Its Sequence |
| Q35392822 | Induction of humoral immune response against Plasmodium falciparum sporozoites by immunization with a synthetic peptide mimotope whose sequence was derived from screening a filamentous phage epitope library |
| Q48036671 | Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin |
| Q72404186 | Inhibition of Plasmodium berghei sporozoite invasion of cultured hepatoma cells |
| Q44908058 | Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax |
| Q24650673 | Inhibitory monoclonal antibody against a (myristylated) small-molecular-weight antigen from Plasmodium falciparum associated with the parasitophorous vacuole membrane |
| Q48394125 | Isolate-specific S-antigen of Plasmodium falciparum contains a repeated sequence of eleven amino acids |
| Q37143190 | Isolation of three distinct parasite populations expressing different circumsporozoite proteins from the Philippine strain of Plasmodium knowlesi |
| Q40157659 | Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen |
| Q44142690 | Localization of circumsporozoite protein in the sporogonic stages of Plasmodium vivax. |
| Q39846325 | Malaria and the liver |
| Q30039117 | Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes |
| Q33889091 | Malaria circumsporozoite protein inhibits protein synthesis in mammalian cells |
| Q35630416 | Malaria vaccine developments |
| Q26781372 | Malaria vaccines: identifying Plasmodium falciparum liver-stage targets |
| Q40196682 | Malaria: immunity, vaccination and immunodiagnosis |
| Q36376823 | Mapping the active site of CD59 |
| Q24798369 | Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor |
| Q36312453 | Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi |
| Q38891923 | Monoclonal antibodies produced against sporozoites of the human parasite Plasmodium malariae abolish infectivity of sporozoites of the simian parasite Plasmodium brasilianum |
| Q47848296 | Monoclonal antibodies recognize a processing dependent epitope present in the mature CS protein of various plasmodial species |
| Q44167205 | Monoclonal antibodies to circumsporozoite proteins identify the species of malaria parasite in infected mosquitoes |
| Q38892110 | Monoclonal antibody identifies circumsporozoite protein of Plasmodium malariae and detects a common epitope on Plasmodium brasilianum sporozoites. |
| Q43615782 | Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei |
| Q34462075 | Peptide-based subunit vaccines against pre-erythrocytic stages of malaria parasites |
| Q33318466 | Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein |
| Q47830000 | Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein |
| Q36726849 | Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses |
| Q34462082 | Plasmodium vivax malaria vaccine development |
| Q34416103 | Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates |
| Q38591761 | Pre-erythrocytic stage malaria parasites: non-circumsporozoite protein antigens |
| Q34546208 | Preclinical Vaccine Study of Plasmodium vivax Circumsporozoite Protein Derived-Synthetic Polypeptides Formulated in Montanide ISA 720 and Montanide ISA 51 Adjuvants |
| Q37392892 | Predicted conformations for the immunodominant region of the circumsporozoite protein of the human malaria parasite Plasmodium falciparum |
| Q30043830 | Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design |
| Q33270408 | Prevention and treatment of vivax malaria |
| Q48022505 | Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge |
| Q34280935 | Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity |
| Q37336064 | Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin |
| Q41701401 | Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts. |
| Q35590960 | Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion |
| Q36362740 | Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. |
| Q38665423 | Rationale for the development of an engineered sporozoite malaria vaccine |
| Q37169092 | Recombinant peptide replicates immunogenicity of synthetic linear peptide chimera for use as pre-erythrocytic stage malaria vaccine |
| Q36367349 | Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. |
| Q34162092 | Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice |
| Q36053524 | Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains |
| Q34156866 | Ribosome Display of Combinatorial Antibody Libraries Derived from Mice Immunized with Heat-Killed Xylella fastidiosa and the Selection of MopB-Specific Single-Chain Antibodies |
| Q37208075 | Role for the Plasmodium sporozoite-specific transmembrane protein S6 in parasite motility and efficient malaria transmission |
| Q37254129 | Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity |
| Q33960093 | Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum |
| Q37013725 | Stage-specific and species-specific antigens of Plasmodium vivax and Plasmodium ovale defined by monoclonal antibodies. |
| Q41811030 | Structural and functional properties of region II-plus of the malaria circumsporozoite protein |
| Q47976053 | Structural similarities among the protective antigens of sporozoites from different species of malaria parasites |
| Q34054966 | Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparum |
| Q48395969 | Structure of the plasmodium knowlesi gene coding for the circumsporozoite protein |
| Q36349109 | Surface proteins of Plasmodium falciparum merozoites binding to the erythrocyte receptor, glycophorin |
| Q38665396 | Synthetic T and B cell recognition sites: implications for vaccine development |
| Q37882450 | Systematic review of chimpanzee use in monoclonal antibody research and drug development: 1981-2010. |
| Q47989326 | TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella Typhimurium |
| Q36799576 | The ELISA technic in the screening of mosquitoes infected with Plasmodium falciparum |
| Q33984183 | The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion |
| Q64087598 | The Selection of a Hepatocyte Cell Line Susceptible to Sporozoite Invasion That Is Associated With Expression of Glypican-3 |
| Q37615096 | The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for plasmodium sporozoite attachment to target cells. |
| Q39557947 | The biotin-streptavidin system in a two-site ELISA for the detection of plasmodial sporozoite antigen in mosquitoes |
| Q44054674 | The circumsporozoite protein of Plasmodium falciparum is expressed and localized to the cell surface in the free-living ciliate Tetrahymena thermophila |
| Q40826489 | The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite |
| Q56342580 | Unraveling the Plasmodium vivax sporozoite transcriptional journey from mosquito vector to human host |
| Q47878399 | VH and VL region structure of antibodies that recognize the (NANP)3 dodecapeptide sequence in the circumsporozoite protein of Plasmodium falciparum |
| Q42699604 | Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite |
| Q37150329 | Various carrier system(s)- mediated genetic vaccination strategies against malaria |
| Q34119885 | Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice |
| Q38208781 | Western blot assay for quantitative and qualitative antigen detection in vaccine development |
Search more.